SKI Market

Indian Indices

Nifty

24,363.30 -232.85
(-0.95%)

Sensex

79,857.79 -765.47
( -0.95%)

Bank Nifty

55,004.90 -516.25
( -0.93%)

Nifty IT

34,398.50 -328.30
( -0.95%)

Global Indices

Nasdaq

44,202.01 212.36
(0.48%)

Dow Jones

6,410.95 49.95
(0.79%)

Hang Seng

41,765.59 706.44
(1.72%)

Nikkei 225

9,095.73 -5.04
(-0.06%)

Forex

USD-INR

87.56 -0.16
(-0.18%)

EUR-INR

102.07 0.20
(0.20%)

GBP-INR

117.31 0.43
(0.37%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Ambalal Sarabhai Enterprises Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500009

INE432A01017

6.3281235

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMBASARABH

77.56

231.82

EPS(TTM)

Face Value()

Div & Yield %

0.39

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	4.04	3.81	3.71	0.13	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4.04	3.81	3.71	0.13	0.00	0.00
Other Income	20.50	7.89	18.66	39.54	29.61	24.61
Stock Adjustments	0.00	0.00	0.02	0.00	0.00	0.00
Total Income	24.54	11.70	22.39	39.67	29.61	24.61
EXPENDITURE :
Raw Materials	3.95	3.71	3.65	0.12	0.00	0.00
Power & Fuel Cost	0.06	0.10	0.10	0.07	0.11	0.08
Employee Cost	0.87	2.04	2.21	2.51	3.26	3.35
Other Manufacturing Expenses	0.36	0.35	0.31	0.35	0.70	0.18
Selling & Administrative Expenses	4.00	1.88	2.19	2.04	3.03	3.46
Miscellaneous Expenses	6.77	0.53	9.34	30.68	31.05	0.78
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	16.01	8.62	17.80	35.77	38.14	7.85
Operating Profit	8.52	3.09	4.59	3.89	-8.53	16.75
Interest	0.34	2.16	0.11	0.25	0.56	0.46
Gross Profit	8.18	0.93	4.48	3.64	-9.09	16.29
Depreciation	0.10	0.12	0.15	0.19	0.38	0.39
Profit Before Tax	8.08	0.81	4.33	3.45	-9.47	15.90
Tax	0.00	-2.15	0.00	-0.25	0.21	0.04
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.16	0.39	0.23	0.75	-0.29	0.31
Reported Net Profit	8.24	2.58	4.11	2.96	-9.39	15.55
Extraordinary Items	5.22	0.00	-0.69	-0.43	-6.76	0.28
Adjusted Net Profit	3.02	2.58	4.80	3.39	-2.63	15.27
Adjustment below Net Profit	-0.04	0.00	0.03	0.02	-0.07	-0.09
P & L Balance brought forward	-102.92	-105.50	-109.64	-112.62	-103.16	-118.62
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-94.72	-102.92	-105.50	-109.64	-112.62	-103.16
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.08	0.34	0.54	0.39	-1.22	2.03
Earnings Per Share(Adj)-Unit Curr	1.08	0.34	0.54	0.39	-1.22	2.03
Book Value-Unit Curr	6.33	5.26	4.94	4.40	4.02	5.25
Book Value(Adj)-Unit Curr	6.33	5.26	4.94	4.40	4.02	5.25

24,363.30 -232.85 (-0.95%)

79,857.79 -765.47 ( -0.95%)

55,004.90 -516.25 ( -0.93%)

34,398.50 -328.30 ( -0.95%)

44,202.01 212.36 (0.48%)

6,410.95 49.95 (0.79%)

41,765.59 706.44 (1.72%)

9,095.73 -5.04 (-0.06%)

87.56 -0.16 (-0.18%)

102.07 0.20 (0.20%)

117.31 0.43 (0.37%)

0.59 0.00 (-0.07%)